John M. Evans, CEO: Beam Therapeutics BEAM Sell · Filed 24/06/28

Trade details

Type: Insider sale
Amount: $1,470,000
Shares · price: 60,000 sh · $24.50 a share
Held after: 998,343 sh
Stock: Beam Therapeutics BEAM
Person: John M. EvansCEO
Trade date: 24/06/27
Filed: 24/06/28
Days to filing: 1 days

Sold 5.7% of holdings

Share of holding sold: 5.7%

Beam Therapeutics trades, last 26 weeks

What else happened in Beam Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/28~24/07/27

John M. Evans's recent trades

John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$857.7K
25,000 sh
$857.7K
Filed 06/30
Traded 06/30
John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$887.4K
25,000 sh
$887.4K
Filed 06/29
Traded 06/29
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$739.3K
30,078 sh
$739.3K
Filed 04/06
Traded 04/01
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$569K
25,000 sh
$569K
Filed 04/01
Traded 03/31
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$559.3K
25,000 sh
$559.3K
Filed 04/01
Traded 03/30

John M. Evans, CEO — sold $1.5M of Beam Therapeutics BEAM · 5.7% of holdings · 10b5-1 plan | Whalegun